Yanghe Shares Say Third-Quarter Revenue Fell 61.1% Year Over Year
Yanghe shares said third-quarter revenue fell 61.1% year over year.
Related stories
Ligand Expects 2026 Revenue of $270M-$310M
Ligand Pharmaceuticals expects 2026 revenue of $270 million to $310 million, versus a FactSet estimate of $289.5 million.
M impact | EARNINGS | Oct 29, 2026, 11:28 AM UTC
Stagwell Sets FY Adjusted EPS Outlook at $1.07-$1.21
M impact | EARNINGS | Oct 29, 2026, 11:28 AM UTC
HGTECH Says Third-Quarter Revenue Rose 41.8% Year Over Year
HGTECH said third-quarter revenue increased 41.8% from a year earlier.
M impact | EARNINGS | Oct 29, 2026, 11:27 AM UTC
Ligand Expects 2026 Adjusted EPS of $9.50-$9.75
Ligand Pharmaceuticals expects 2026 adjusted EPS of $9.50-$9.75, versus a FactSet estimate of $9.35.
M impact | EARNINGS | Oct 29, 2026, 11:27 AM UTC
Indian Energy Exchange Reports September-Quarter Revenue of 1.67 Billion Rupees
Indian Energy Exchange reported consolidated revenue from operations of 1.67 billion rupees for the September quarter.
M impact | EARNINGS | Oct 29, 2026, 11:27 AM UTC
Sirius XM Reports Q3 EPS of $0.78
M impact | EARNINGS | Oct 29, 2026, 11:26 AM UTC